Medroxyprogesterone Acetate 150 mg/mL

Medroxyprogesterone Acetate 150 mg/mL is an injectable suspension used for various hormonal treatments. This extended-release formulation is designed for intramuscular administration and is manufactured by Amphastar Pharmaceuticals, Inc.

Medroxyprogesterone Acetate is commonly used for hormonal therapy, including contraception and treatment of certain gynecological conditions. It may also be prescribed for managing symptoms related to hormonal imbalances. The medication works by altering the hormonal environment in the body, which can help regulate menstrual cycles or prevent pregnancy.

Common effects of Medroxyprogesterone Acetate may include changes in menstrual bleeding patterns, weight fluctuations, and mood swings. Some users may experience headaches, dizziness, or breast tenderness. These effects vary among individuals and typically subside as the body adjusts to the medication.

Medroxyprogesterone Acetate should be used with caution in individuals with a history of blood clots, liver disease, or breast cancer. It is important to discuss your medical history with a healthcare provider before starting this medication. Regular monitoring may be recommended to ensure safety and effectiveness.

Medroxyprogesterone Acetate may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. It is advisable to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements, to avoid potential interactions.